OTC Markets OTCPK - Delayed Quote USD

United Health Products, Inc. (UEEC)

0.0540

-0.0012

(-2.17%)

At close: January 14 at 2:58:57 PM EST

United Health Products Provides Update on Clinical Study Process

MT. LAUREL, N.J., Dec. 02, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s planned clinical study. As previously disclosed, United Health Products is conducting a clinical trial of its CelluSTAT Hemostatic Gauze product (formerly branded as HemoStyp) in response to the FDA’s request for additional clinical data. On November 29th, the company submitted to the FDA an Investigational Device Exemption application (IDE), the approval of wh

GlobeNewswire last month

UEEC
-2.17%
United Health Products Provides Update on FDA PMA Application

MOUNT LAUREL, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval (PMA) application process. Following the company’s August 15, 2024 submission of its Submission Issue Request (SIR) to the FDA which responded to certain questions in the FDA’s June 18 letter and described the company’s approach to addressing certain FDA-identified deficiencies in its PMA application, the company held a videoconference

GlobeNewswire 2 months ago

UEEC
-2.17%
United Health Products Submits Response Letter to FDA

MT. LAUREL, NJ, Aug. 19, 2024 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval (PMA) application process. Following the company’s March 21 submission of its PMA application and the FDA’s June 18 “Deficiencies Letter” to the company listing certain questions and comments on various elements of the application, on August 15, UHP submitted a Submission Issue Request to the FDA responding to certain questions and detailin

GlobeNewswire 4 months ago

UEEC
-2.17%
United Health Products Provides Update on FDA PMA Application Process

MOUNT LAUREL, NJ - (NewMediaWire) - June 24, 2024 - United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval (PMA) application process. Following the company's March 21 submission of its PMA applic...

NewMediaWire 6 months ago

UEEC
-2.17%
United Health Products Submits Full FDA PMA Application

MOUNT LAUREL, NJ, March 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process. The company confirms that it has submitted via the FDA eSTAR portal its Premarket Approval (PMA) application for its absorbable hemostatic gauze, which will now be reviewed by the FDA and Health Canada. Information on the FDA review process for PMA applications can be found on the FDA website at:

GlobeNewswire 9 months ago

UEEC
-2.17%
United Health Products Reports on FDA Application Status

MESQUITE, NV - (NewMediaWire) - January 19, 2024 - United Health Products (UEEC) reports today on the receipt and review of final reports on product sterilization and stability testing for its hemostatic gauze. As previously disclosed, UHP has been w...

NewMediaWire 11 months ago

UEEC
-2.17%

Performance Overview

Return	UEEC	S&P 500
YTD	-10.00%	-1.08%
1-Year	-75.45%	+22.14%
3-Year	-91.58%	+25.41%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

United Health Products, Inc. (UEEC)

United Health Products Provides Update on Clinical Study Process

United Health Products Provides Update on FDA PMA Application

United Health Products Submits Response Letter to FDA

United Health Products Provides Update on FDA PMA Application Process

United Health Products Submits Full FDA PMA Application

United Health Products Reports on FDA Application Status

Performance Overview